2008:Bernadette Breant - University Pierre et Marie Curie – Paris, FranceThe role of glucorticoids on pancreas development and the induction of type 2 diabetes: genetic approach in mice and in vitro studies Harry Heimberg - Free University Brussels - Belgium Activation and expansion of beta cell progenitors in the adult pancreas Patrick Jacquemin - Louvain Catholic University – Brussels, Belgium Beta cell neogenesis in hnf6-/- mice: characterisation and translation of the underlying mechanism to the production of beta cells in vitro Kathrin Maedler - University of Bremen - Germany Genetic modifications in the TCF7L2 gene regulate beta cell function and survival in type 2 diabetes Stephan Speier - Karolinska Institutet - Stockholm, Sweden Non-invasive in vivo imaging of pancreatic functional beta cell mass regulation Emmanuel Van Obberghen - Nice University Hospital - France Beta cell failure and progression to type 2 diabetes: role of muscle-derived molecules 2007:Amar Abderrahmani - UCHUV-Hospital - Lausanne, SwitzerlandRole of human oxidised low density lipoprotein and high density lipoprotein in pancreatic beta cells: relevance for the molecular pathogenesis of diabetes Stefano del Prato - University of Pisa - Italy Prevalence of the TCF7L2 polymorphisms in a high risk type 2 diabetes population and their role in determining different pathogenic features as well as response to incretin-based therapy Marc Donath - University Hospital Zurich - Switzerland Regulation of islet inflammatory CXC chemokines and angiogenesis by the Fas-FLIP pathway Valdemar Grill - University Hospital Trondheim - Norway Mitochondrial plasticity and function in beta cells: effects of diabetes and hypoxia Noel Morgan - Peninsula Medical School - Plymouth, U.K. Mechanisms by which interleukin-4 protects pancreatic beta cells against pro-inflammatory cytokine induced cell death Hindrick Mulder - Lund University - Sweden Metabolic analysis of pancreatic beta cells Shanta Persaud - King's College London - U.K. Role of p8 in beta cell mass expansion and survival 2006:Lena Eliasson - Lund University - SwedenRole of miR-375 and its target proteins in insulin secretion Jorge Ferrer - Fundacio Clinic Barcelona - Spain Novel insights into the role of Dipetidylpeptidase IV in pancreatic beta-cell function Françoise Homo-Delarche - Paris 7 University - France Islet vasculopathy in type 2 diabetes: the Goto-Kakizaki (GK) rat paradigm Leif Jansson - Uppsala University - Sweden Blood lipids and pancreatic islet blood flow: possible pathogenetic importance for type 2 diabetes Andreas Lechner - Ludwig-Maximilians-University - Munich, Germany Analysis of the functional role of osteoprotegerin (OPG) in pancreatic islets Michael Ristow - Jena University - Germany Maintenance of pancreatic beta-cell mass by conditional knock-in of mitochondrial frataxin into diabetes-prone mice Stephan Schneider - Ruhr-University Bochum - Germany In vivo imaging of the islet-cell mass in normal and diabetic states Anders Tengholm - Uppsala University - Sweden Spatio-temporal dynamics of cAMP signals in pancreatic β-cells 2005:Francesco Beguinot - Federico II University - Naples, ItalyThe control of beta-cell function by ped/pea-15 gene and its abnormality in type 2 diabetes Peter Bergsten - Uppsala University - Sweden Unravelling mechanisms of β-cell glucolipotoxicity Marc Donath - Zurich University - Switzerland Regulation of beta-cell secretory function via FAS signalling Jean-Christophe Jonas - Louvain Catholique University - Brussels, Belgium Mechanisms of β-cell glucotoxicity Erik Renström - Lund University - Sweden Identification of candidate genes for type 2 diabetes: Molecular investigations of mechanisms for defective insulin secretion related to a major species-conserved susceptibility locus Emmanuel Van Obberghen - INSERM - Nice, France Role of SOCS proteins in beta cell function and survival |